Regional contributions of nitric oxide synthase to cholinergic cutaneous vasodilatation and sweating in young men.
What is the central question of this study? We evaluated whether regional variations exist in nitric oxide (NO) dependent cutaneous vasodilatation and sweating during cholinergic stimulation. What is the main finding and its importance? Peak cutaneous vasodilatation and sweating were greater on the torso than the forearm. Further, we found that NO is an important modulator of cholinergic cutaneous vasodilatation, but not sweating, across body regions with a greater NO-contribution to cutaneous vasodilatation in the limb compared to the torso. These findings advance our understanding of the mechanisms influencing regional variations in cutaneous vasodilator and sweating responses to pharmacological stimulation. Regional variations in cutaneous vasodilatation and sweating exist across the body. Nitric oxide (NO) is an important modulator of these heat loss responses on the forearm. However, whether regional differences in NO-dependent cutaneous vasodilatation and sweating exist remains uncertain. In fourteen habitually active young men (23 ± 4 years), cutaneous vascular conductance (CVC%max ) and local sweat rate (LSR) were assessed at six skin sites. On each of the dorsal forearm, chest, and upper back (trapezius), sites were continuously perfused with either 1) lactated Ringer's (control) or 2) 10 mM Nω -nitro-L-arginine (L-NNA, NO synthase inhibitor) dissolved in Ringer solution, via microdialysis. At all sites cutaneous vasodilatation and sweating were induced by co-administration of the cholinergic agonist methacholine (1, 10, 100, 1000, 2000 mM; 25 min per dose) followed by 50 mM sodium nitroprusside (20-25 min) to induce maximum vasodilatation. L-NNA attenuated CVC%max relative to control for all regions (all P < 0.05) and NO-dependent vasodilatation was greater at the forearm compared to the back and chest (both P < 0.05). Further, maximum vasodilatation was higher at the back and chest relative to the forearm (both P < 0.05). Conversely, L-NNA had negligible effects on sweating across the body (all P > 0.05). Peak LSR was higher at the back relative to the forearm (P < 0.05) with a similar trend observed for the chest. In habitually active young men, NO-dependent cholinergic cutaneous vasodilatation varies across the body, while the contribution to cholinergic sweating was negligible. These findings advance our understanding of the mechanisms influencing regional variations in cutaneous vasodilation and sweating during pharmacological stimulation. This article is protected by copyright. All rights reserved.